Table 3.
The estimated infarction size in patients with AMI
| The peak value of myocardial enzyme | Before PS match | P value | After PS match | P value | ||
|---|---|---|---|---|---|---|
| ACEI/ARB(-) | ACEI/ARB(+) | ACEI/ARB(-) | ACEI/ARB(+) | |||
| (n: 402) | (n: 251) | (n: 298) | (n: 236) | |||
| pMYO,ng/ml | 50.1 (26.0, 150.3) | 46.0 (17.4, 146.5) | NS | 50.4 (28.3, 173.8) | 46.1 (17.8, 150.0) | NS |
| pCK-MB,ng/ml | 28.4 (8.0, 116.0) | 21.3 (5.2, 89.2) | < 0.05 | 28.7 (8.2, 119.3) | 21.7 (5.2, 90.9) | < 0.05 |
| pTNI,ng/ml | 7.7 (2.3, 27.0) | 5.4 (1.0, 22.5) | < 0.05 | 6.8 (2.2, 22.9) | 5.7 (1.0, 24.3) | < 0.05 |
Data are presented as IQR
AMI acute myocardial infarction, ACEI/ARB angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, pMYO the peak value of myoglobin, pCK-MB the peak value of creatine kinase MB, pTNI the peak value of troponin I, NS non-significant